Viewing Study NCT03133234


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2026-01-07 @ 2:09 AM
Study NCT ID: NCT03133234
Status: COMPLETED
Last Update Posted: 2018-11-20
First Post: 2017-04-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLC
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module